# 8-K filed: SANGAMO THERAPEUTICS, INC

> sec 8k · VERIFIED · 2026-06-23

<b>Filed:</b> 2026-06-23 <b>AccNo:</b> 0001193125-26-278582 <b>Size:</b> 169 KB
<br>Item 1.01: Entry into a Material Definitive Agreement
<br>Item 1.03: Bankruptcy or Receivership
<br>Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
<br>Item 2.05: Cost Associated with Exit or Disposal Activities

- Company: SANGAMO THERAPEUTICS, INC
- Sector: biotech
- Primary source: https://www.sec.gov/Archives/edgar/data/1001233/000119312526278582/0001193125-26-278582-index.htm

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.
